DMK
Vanguard Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-33,990
| Closed | -$23.8K | – | 4533 |
|
|
2023
Q4 | $23.8K | Buy |
33,990
+3,900
| +13% | +$2.73K | ﹤0.01% | 4430 |
|
|
2023
Q3 | $20.7K | Sell |
30,090
-820
| -3% | -$565 | ﹤0.01% | 4496 |
|
|
2023
Q2 | $74.5K | Sell |
30,910
-6,453,035
| -100% | -$15.6M | ﹤0.01% | 4414 |
|
|
2023
Q1 | $751K | Hold |
6,483,945
| – | – | ﹤0.01% | 3995 |
|
|
2022
Q4 | $1.1M | Buy |
6,483,945
+3,257
| +0.1% | +$551 | ﹤0.01% | 3880 |
|
|
2022
Q3 | $1.29M | Hold |
6,480,688
| – | – | ﹤0.01% | 3920 |
|
|
2022
Q2 | $3.25M | Hold |
6,480,688
| – | – | ﹤0.01% | 3586 |
|
|
2022
Q1 | $3.7M | Sell |
6,480,688
-38,168
| -0.6% | -$21.8K | ﹤0.01% | 3669 |
|
|
2021
Q4 | $3.94M | Buy |
6,518,856
+9,402
| +0.1% | +$5.69K | ﹤0.01% | 3740 |
|
|
2021
Q3 | $6.32M | Buy |
6,509,454
+195,613
| +3% | +$190K | ﹤0.01% | 3510 |
|
|
2021
Q2 | $6.95M | Buy |
6,313,841
+582,319
| +10% | +$641K | ﹤0.01% | 3401 |
|
|
2021
Q1 | $5.39M | Buy |
5,731,522
+3,667,799
| +178% | +$3.45M | ﹤0.01% | 3494 |
|
|
2020
Q4 | $1M | Buy |
2,063,723
+110,300
| +6% | +$53.5K | ﹤0.01% | 3827 |
|
|
2020
Q3 | $1.53M | Buy |
1,953,423
+53,872
| +3% | +$42.2K | ﹤0.01% | 3557 |
|
|
2020
Q2 | $1.02M | Buy |
1,899,551
+13,314
| +0.7% | +$7.14K | ﹤0.01% | 3614 |
|
|
2020
Q1 | $673K | Hold |
1,886,237
| – | – | ﹤0.01% | 3605 |
|
|
2019
Q4 | $1.32M | Sell |
1,886,237
-42,857
| -2% | -$30K | ﹤0.01% | 3563 |
|
|
2019
Q3 | $1.36M | Buy |
1,929,094
+137,828
| +8% | +$97.1K | ﹤0.01% | 3564 |
|
|
2019
Q2 | $2.33M | Buy |
1,791,266
+77,498
| +5% | +$101K | ﹤0.01% | 3433 |
|
|
2019
Q1 | $3.62M | Buy |
1,713,768
+650,256
| +61% | +$1.37M | ﹤0.01% | 3258 |
|
|
2018
Q4 | $2.39M | Sell |
1,063,512
-574,001
| -35% | -$1.29M | ﹤0.01% | 3320 |
|
|
2018
Q3 | $5.73M | Buy |
1,637,513
+348,645
| +27% | +$1.22M | ﹤0.01% | 3182 |
|
|
2018
Q2 | $4.13M | Buy |
1,288,868
+7,800
| +0.6% | +$25K | ﹤0.01% | 3268 |
|
|
2018
Q1 | $4.48M | Buy |
1,281,068
+43,272
| +3% | +$151K | ﹤0.01% | 3193 |
|
|
2017
Q4 | $5.45M | Buy |
1,237,796
+105,767
| +9% | +$465K | ﹤0.01% | 3099 |
|
|
2017
Q3 | $5.91M | Buy |
1,132,029
+189,089
| +20% | +$988K | ﹤0.01% | 3052 |
|
|
2017
Q2 | $4.9M | Buy |
942,940
+171,167
| +22% | +$890K | ﹤0.01% | 3090 |
|
|
2017
Q1 | $3.28M | Buy |
771,773
+87,974
| +13% | +$374K | ﹤0.01% | 3217 |
|
|
2016
Q4 | $2.15M | Buy |
683,799
+135,485
| +25% | +$427K | ﹤0.01% | 3341 |
|
|
2016
Q3 | $1.88M | Buy |
548,314
+212,500
| +63% | +$729K | ﹤0.01% | 3418 |
|
|
2016
Q2 | $940K | Buy |
335,814
+60,197
| +22% | +$169K | ﹤0.01% | 3619 |
|
|
2016
Q1 | $1.69M | Buy |
275,617
+13,532
| +5% | +$83K | ﹤0.01% | 3441 |
|
|
2015
Q4 | $1.42M | Buy |
262,085
+6,603
| +3% | +$35.7K | ﹤0.01% | 3518 |
|
|
2015
Q3 | $1.01M | Buy |
255,482
+4,100
| +2% | +$16.2K | ﹤0.01% | 3631 |
|
|
2015
Q2 | $1.06M | Buy |
251,382
+15,142
| +6% | +$63.6K | ﹤0.01% | 3648 |
|
|
2015
Q1 | $931K | Buy |
236,240
+176,282
| +294% | +$695K | ﹤0.01% | 3650 |
|
|
2014
Q4 | $370K | Buy |
59,958
+38,170
| +175% | +$236K | ﹤0.01% | 3806 |
|
|
2014
Q3 | $102K | Buy |
+21,788
| New | +$102K | ﹤0.01% | 3952 |
|